User:Mr. Ibrahem/Panobinostat

Panobinostat, sold under the brand name Farydak, is a medication used to treat multiple myeloma. It is used when at least two other treatments have failed. It is taken by mouth. It is used together with bortezomib and dexamethasone.

Common side effects include diarrhea, tiredness, nausea, swelling, fever, weight loss, high magnesium, low calcium, low potassium, low white blood cells, and low platelets. Other side effects may include bleeding, QT prolongation, and infections. Use during pregnancy may harm the baby. It is a histone deacetylase inhibitor (HDAC inhibitor).

Panobinostat was approved for medical use in the United States and Europe in 2015. In the United Kingdom six doses costs the NHS about £4,700 as of 2021. This amount in the United States costs about 15,000 USD.